Chemotherapy Regimens for Small Cell Lung Cancer in the UK
Author Information
Author(s): Sambrook R J, Girling D J
Primary Institution: Medical Research Council Clinical Trials Unit
Hypothesis
What chemotherapy regimens are used to treat small cell lung cancer in the UK?
Conclusion
The study found a wide variation in chemotherapy regimens used for treating small cell lung cancer in the UK.
Supporting Evidence
- 1214 questionnaires were sent out, and responses were received from 1070 clinicians.
- 266 clinicians treated SCLC with chemotherapy.
- 34 regimens were reported with 151 different combinations of dose and schedule.
Takeaway
Doctors in the UK use many different treatments for small cell lung cancer, and this study helps us understand what those treatments are.
Methodology
A survey was conducted among oncologists and physicians to gather data on chemotherapy regimens used for SCLC.
Potential Biases
Potential bias in responses due to self-reporting and variation in local practices.
Limitations
The study may not capture all treatment practices as it relies on self-reported data from clinicians.
Participant Demographics
Responses were collected from 1070 clinicians treating SCLC in the UK.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website